ELAGORYN

What this means for you

Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97774625

Registration number

7674835

Mark type

Stylized text

Filed

31 Jan 2023

Published for opposition

12 Dec 2023

Registered

04 Feb 2025

Attorney of record

Elizabeth K. Rucki

Goods and services

• Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Owner

• Glaxo Group Limited, Stevenage, GB
• Glaxo Group Limited, Stevenage, GB
• Glaxo Group Limited, Stevenage, GB

Prosecution history

• 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
• 13 Jan 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
• 30 Jul 2024 — NOTICE OF ALLOWANCE CANCELLED
• 30 Jul 2024 — TEAS DELETE 1(B) BASIS RECEIVED
• 06 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 12 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 12 Dec 2023 — PUBLISHED FOR OPPOSITION
• 22 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 03 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 30 Oct 2023 — ASSIGNED TO EXAMINER
• 12 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 12 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 12 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 17 Feb 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED